Achyut Healthcare Ltd
Incorporated in 1996, Achyut Healthcare Ltd is a pharmaceutical trading company dealing in API, Pharmaceutical products, medical devices, etc.[1]
- Market Cap ₹ 122 Cr.
- Current Price ₹ 5.20
- High / Low ₹ 6.80 / 2.82
- Stock P/E 285
- Book Value ₹ 1.34
- Dividend Yield 0.00 %
- ROCE 2.26 %
- ROE 1.77 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
Cons
- Stock is trading at 3.88 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 1.95% over last 3 years.
- Company has high debtors of 160 days.
- Promoter holding has decreased over last 3 years: -6.06%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 0.67 | 0.33 | 0.27 | 4.05 | 2.70 | 6.14 | 3.05 | |
| 0.66 | 0.32 | 0.26 | 4.08 | 2.97 | 6.12 | 3.25 | |
| Operating Profit | 0.01 | 0.01 | 0.01 | -0.03 | -0.27 | 0.02 | -0.20 |
| OPM % | 1.49% | 3.03% | 3.70% | -0.74% | -10.00% | 0.33% | -6.56% |
| 0.00 | 0.01 | 0.00 | 0.14 | 0.59 | 0.73 | 0.92 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 |
| Profit before tax | 0.01 | 0.02 | 0.01 | 0.10 | 0.31 | 0.74 | 0.70 |
| Tax % | 300.00% | 0.00% | 0.00% | 60.00% | 25.81% | 32.43% | 22.86% |
| -0.01 | 0.01 | 0.01 | 0.04 | 0.23 | 0.50 | 0.55 | |
| EPS in Rs | -0.02 | 0.02 | 0.02 | 0.00 | 0.01 | 0.02 | 0.02 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 56% |
| 3 Years: | -9% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 123% |
| 3 Years: | 140% |
| TTM: | -35% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 39% |
| 1 Year: | 76% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 2% |
| 3 Years: | 2% |
| Last Year: | 2% |
Balance Sheet
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.25 | 0.25 | 0.25 | 6.74 | 9.35 | 16.83 | 23.56 | 23.56 |
| Reserves | -0.05 | -0.04 | 0.00 | 2.34 | 5.18 | 13.93 | 7.74 | 7.98 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.04 | 0.06 | 0.25 | 0.86 | 0.81 | 0.19 | 1.29 | 2.48 | |
| Total Liabilities | 0.24 | 0.27 | 0.50 | 9.94 | 15.34 | 30.95 | 32.59 | 34.02 |
| 0.00 | 0.00 | 0.00 | 0.03 | 0.05 | 0.06 | 0.03 | 0.26 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 3.49 | 9.16 | 18.19 | 24.38 |
| Investments | 0.00 | 0.00 | 0.00 | 1.70 | 1.30 | 0.00 | 0.00 | 0.00 |
| 0.24 | 0.27 | 0.50 | 8.21 | 10.50 | 21.73 | 14.37 | 9.38 | |
| Total Assets | 0.24 | 0.27 | 0.50 | 9.94 | 15.34 | 30.95 | 32.59 | 34.02 |
Cash Flows
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| -0.03 | -0.02 | 0.01 | -6.96 | -0.43 | -0.36 | -4.06 | |
| 0.00 | 0.00 | 0.00 | -1.60 | -4.81 | -15.23 | 4.69 | |
| 0.00 | 0.00 | 0.00 | 8.79 | 5.21 | 15.72 | 0.00 | |
| Net Cash Flow | -0.03 | -0.02 | 0.01 | 0.24 | -0.03 | 0.14 | 0.62 |
Ratios
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 54.48 | 188.03 | 378.52 | 18.02 | 36.50 | 24.37 | 160.36 |
| Inventory Days | 0.00 | 0.00 | 158.70 | 14.29 | 59.59 | 3.96 | 24.16 |
| Days Payable | 380.87 | 41.78 | 55.87 | 12.54 | 143.71 | ||
| Cash Conversion Cycle | 54.48 | 188.03 | 156.34 | -9.46 | 40.22 | 15.79 | 40.81 |
| Working Capital Days | 76.27 | 210.15 | 216.30 | 603.83 | 1,257.22 | 1,242.43 | 1,169.20 |
| ROCE % | 9.76% | 4.35% | 2.14% | 2.63% | 3.27% | 2.26% |
Insights
In beta| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Capital Work In Progress (CWIP) INR Lakhs |
|
||||
| Domestic Sales INR Lakhs |
|||||
| Export Sales INR Lakhs |
|||||
| Manufacturing Status Status |
|||||
| Number of Permanent Employees Count |
|||||
| Trade Receivable Turnover Ratio Ratio |
|||||
Documents
Announcements
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 20 Feb
- Shareholder Meeting / Postal Ballot-Outcome of EGM 19 Feb
-
Notice Of Extra-Ordinary General Meeting Dated January 21, 2026
5 Feb - EGM on Feb 19, 2026 to increase authorised capital by Rs2 crore and preferentially issue 58,00,000 shares at Rs6 (₹3.48Cr).
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
24 Jan - Extract of Newspaper Publication Compliance under Regulation 47 of the SEBi (LODR) Regulation, 2015
-
Notice Of Extra Ordinary General Meeting In Compliance With Regulation 30 Of The SEBI (LODR) Regulations, 2015 ('Listing Regulations')
23 Jan - EGM Feb 19, 2026 to approve authorised capital increase and preferential equity issue.
Business Overview:[1]
Company is in the manufacturing of
pharmaceutical formulations in the
forms of Tablets, Capsules, Oral liquid
and Injectables.